Mark Evan Jones - Aug 9, 2021 Form 4/A - Amendment Insider Report for Goosehead Insurance, Inc. (GSHD)

Role: CEO, Director, Member of 10% owner group, 10%+ Owner
Signature: /s/ P. Ryan Langston, as Attorney-in-Fact for Mark Evan Jones
Stock symbol: GSHD
Transactions as of: Aug 9, 2021
Transactions value $: -$2,348,209
Form type: 4/A - Amendment
Date filed: 8/11/2021, 09:48 PM
Date Of Original Report: Aug 9, 2021
Previous filing: Aug 9, 2021
Next filing: Aug 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GSHD	Class A Common Stock	Options Exercise	$201K	+20.1K	+7.03%	$10.00^*	306K	Aug 9, 2021	Direct	F1
transaction	GSHD	Class A Common Stock	Sale	-$37.8K	-308	-0.1%	$122.61	306K	Aug 9, 2021	Direct	F1, F2
transaction	GSHD	Class A Common Stock	Sale	-$48.4K	-390	-0.13%	$124.19	306K	Aug 9, 2021	Direct	F1, F3
transaction	GSHD	Class A Common Stock	Sale	-$78.5K	-627	-0.21%	$125.27	305K	Aug 9, 2021	Direct	F1, F4
transaction	GSHD	Class A Common Stock	Sale	-$986K	-7.79K	-2.56%	$126.54	297K	Aug 9, 2021	Direct	F1, F5
transaction	GSHD	Class A Common Stock	Sale	-$1.4M	-11K	-3.71%	$127.00	286K	Aug 9, 2021	Direct	F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GSHD	Employee Stock Options (right to buy)	Options Exercise	$0	-20.1K	-6.8%	$0.00	276K	Aug 9, 2021	Class A Stock	20.1K	$10.00	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This does not reflect shares directly held by the reporting person's spouse, who is independently a reporting person of the issuer.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.59 to $123.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.78 to $124.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.79 to $125.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.83 to $126.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.83 to $127.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F7	One third (1/3rd) of the shares subject to the option shall vest and become exercisable, subject to continued employment, on each of the second, third and fourth anniversaries of the grant date; provided, that all shares subject to the option will vest and become exercisable if Mr. Jones's employment is terminated without "cause" or for "good reason" (each as defined in either Mr. Jones's option award agreement or the issuer's omnibus incentive plan) within six month following a "change in control" (as defined in the issuer's omnibus incentive plan).